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Abstract
Background Random duodenal biopsy to exclude coeliac disease during upper gastrointestinal endoscopy for the investiga-
tion of iron deficiency anaemia remains a common procedure, but is expensive and time-consuming. Serological investigation 
for coeliac disease is also recommended, having excellent accuracy with the added benefit of lower cost. This study sought 
to examine the utility of duodenal biopsy and coeliac serology in the diagnosis of coeliac disease.
Methods A prospectively maintained database was interrogated to identify all patients having upper gastrointestinal endos-
copy for the investigation of anaemia between January 01, 2016, and December 31, 2016.
Results Of the 1131 patients having an endoscopy, coeliac serology was measured in only 412 (36%) and was positive in 9 
cases (2%), leading to 6 histological diagnoses of coeliac disease and 3 false positives. Two-hundred and seventy-four patients 
with negative serology had biopsies taken which were all negative. Only 2/451 (0.4%) patients who had biopsies performed 
in the absence of a serology test were histologically positive for coeliac disease. The cost per diagnosis of a case of coeliac 
disease in those with either negative or absent coeliac serology was £18,839 (US$25,244, €21,196).
Conclusions Random duodenal biopsy is not a cost-effective method of diagnosing coeliac disease and should be replaced 
with pre-endoscopy coeliac serology.
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Introduction
Investigation of anaemia represents a large workload for 
endoscopy services [1] with anaemia cited as the primary 
indication in up to 10% of gastroscopies and 6% of colo-
noscopies [2]. In 2015, 756,600 upper gastrointestinal (GI) 
endoscopies were carried out in England alone [3]. In the 
UK, a large burden of this endoscopy workload falls upon 
colorectal surgeons as the National Institute for Health and 
Care Excellence (NICE) recommends referral of patients 
with iron deficiency anaemia (IDA) to a colorectal clinic 
under the 2-week wait pathway [4].
Luminal investigation remains the gold standard for 
investigation of possible malignancy with sensitivities and 
specificities approaching 100% [5–7]. However, upper GI 
cancer is one of the rarer causes of IDA with as few as 2% of 
luminal investigations finding malignancy as the cause [8].
Other upper GI causes of anaemia include use of non-
steroidal anti-inflammatory drugs, peptic ulceration and pep-
tic erosions, the majority of which can be detected through 
visual assessment of the mucosa alone [9]. Coeliac disease 
is also a common cause of IDA, often diagnosed by demon-
stration of microscopic features of the disease in duodenal 
biopsy [10]. Macroscopic features are mostly absent [11, 
12], and so biopsy of normal looking mucosa is recom-
mended by the British Society of Gastroenterology and other 
bodies in order to exclude coeliac disease as a cause of IDA 
[10, 13, 14].
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Highly sensitive and specific immunological assays for 
the diagnosis of coeliac disease have been developed dur-
ing the past 2 decades, and the use of the coeliac serology 
is recommended in the investigation of IDA [15]. The tests 
are now so reliable that some authors suggest that biopsy 
is not always necessary for the diagnosis of coeliac disease 
[16, 17].
Despite these developments, it remains usual for 
endoscopists to take random duodenal biopsies in the 
investigation of IDA to exclude coeliac disease as a cause 
based on traditional practice and content of guidelines [10, 
13]. However, duodenal biopsy carries potential morbidity 
and mortality [18, 19] and increases financial costs due to 
biopsy equipment, specimen processing and reporting time. 
This study aimed to evaluate the utility and cost of random 
duodenal biopsies compared to serology in the diagnosis of 
coeliac disease in patients being investigated for IDA in one 
teaching hospital in the UK.
Materials and methods
This study was carried out as a service evaluation in a large 
teaching hospital in the UK, which performs over 9000 
upper GI endoscopies each year.
All patients having upper GI endoscopy between January 
01, 2016, and December 31, 2016, for investigation of anae-
mia were identified via a prospective electronic database.
Results of haematological, biochemical and immuno-
logical investigations performed prior to endoscopy were 
obtained from the hospital pathology computer database. 
Similarly, results of duodenal biopsy were retrieved from the 
pathology records. Internal National Health Service costs for 
the processing of serology, histology and biopsy consuma-
bles were obtained from the hospital finance department.
Data were analysed using Microsoft Excel (version 2016, 
Microsoft, USA).
Results
In total, 1150 upper GI endoscopies were carried out for 
the investigation of anaemia in the 2016 calendar year on 
1131 patients. Only 886/1131 patients investigated for 
anaemia had microcytosis (MCV < 88.0) and only 159 
patients had their serum ferritin measured in the investi-
gation of their anaemia. Fifteen patients had an upper GI 
endoscopy for investigation of anaemia with no evidence 
of their serum haemoglobin concentration being below 
135 g/l at any time.
Four hundred and twelve patients (36%) had coeliac 
serology performed prior to their endoscopy. Seven hun-
dred and thirty-four patients (65%) had duodenal biopsy. 
A Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) flow diagram demonstrating the 
clinical pathway followed by all patients having an upper 
GI endoscopy is displayed in Fig. 1.
Coeliac serology was positive in 9/412 patients (2.2%) 
in whom it was measured before the procedure. All 9 of 
these also had duodenal biopsy performed at endoscopy, 
Fig. 1  Strengthening the reporting of observational studies in epidemiology flow diagram demonstrating clinical course of patients having an 
upper gastrointestinal endoscopy
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which was positive for histological markers of coeliac 
disease in 6 cases and was negative in 3 cases. Of the 
403 patients with negative serology, 274 (68%) had duo-
denal biopsy, none of which demonstrated coeliac disease 
(249 biopsies reported as normal and 18 as non-specific 
inflammatory change). Coeliac serology therefore yielded 
3 false positive results and no false negatives making the 
test 100% sensitive and 99% specific.
Of the 719 patients without pre-procedure coeliac serol-
ogy, 451 had duodenal biopsy (63%), 2 were positive for 
coeliac disease (0.4%), non-specific inflammatory changes 
were reported in 37, and the remaining 394 patients had 
biopsies reported as normal.
The internal National Health Service cost price for 
the processing of an IgA TTG (tissue trans-glutaminase) 
titre (the serological test used in our institution) is £6.54 
(US$8.73, €7.36). The cost for consumables used in duo-
denal biopsy is £4.75 for each patient and the cost of pro-
cessing and reporting each duodenal biopsy £47.22 ($63.06, 
€53.13).
The total cost of processing the duodenal biopsies in our 
institution in one calendar year for the investigation of anae-
mia was £38,146 ($50,943, €42,934). £37,678 was spent 
processing biopsies from patients who were either TTG 
negative or had not had their TTG measured, leading to the 
detection of coeliac disease in 2 patients who had not had 
TTG performed: a cost of £18,839 ($25,244, €21,196) per 
case. The cost of measuring TTG in the 719 patients who 
did not have it performed would have been £4702 ($6278, 
€5290).
Discussion
This study suggests that random duodenal biopsy is not cost-
effective for the diagnosis of coeliac disease as a cause of 
IDA and should be abandoned in favour of immunological 
tests. Whilst serology will not identify all cases of coeliac 
disease, these tests are 96–98% sensitive and 95–99% spe-
cific [20]. In our 1 year of investigation of IDA, 2 patients 
with coeliac disease who did not have pre-procedure serol-
ogy were identified by biopsy. The extra cost of identify-
ing each of these cases using a non-selective duodenal 
biopsy policy was £18,839 per case, far in excess of costs 
of diagnosing colorectal cancer in practice (between £7586 
and £9663 per patient) [21] and is difficult to justify in any 
financial climate [22, 23]. Indeed, it is almost certain, given 
the sensitivity of the immunological test, that these cases 
would have been identified by serology, had it been per-
formed before endoscopy.
With cheap and reliable serological tests, coeliac dis-
ease can be excluded without duodenal biopsy [16, 17]. 
Our experience suggests that performing biopsy on those 
with negative TTG is unnecessary and more expensive, and 
although none were seen in our patients, others report a 
small risk of complications associated with biopsy [18, 19].
The increased costs of biopsy over serology may be 
underestimated in this study as we have not costed clinical 
administration time, consumables and postage involved in 
communicating the result of the biopsy to patient and gen-
eral practitioner, nor the delay in informing the patient of the 
outcome of the biopsy. The result of a pre-endoscopy TTG 
test performed on referral for endoscopy would be ready for 
patient and endoscopist at the time of the endoscopy and 
would help to rationalise biopsy practice. Insufficient work-
up for IDA remains an issue in this group of patients [24]. 
Although there were no false negative serology results in 
our year-long series, continued anaemia after iron therapy 
or an ongoing suspicion of a potential missed diagnosis of 
coeliac disease should prompt random duodenal biopsy even 
if serology is negative, as advised by NICE [13].
Conclusions
Random duodenal biopsy to exclude coeliac disease as a 
cause of anaemia is not cost-effective and should be replaced 
with universally performed pre-endoscopy TTG.
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